Skip to content

Clinical Evaluation of Probiotics’ Effect on Sleep Disorder

Clinical Evaluation of Probiotics’ Effect on Sleep Disorder

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080254
Enrollment
Unknown
Registered
2024-01-24
Start date
2024-02-01
Completion date
Unknown
Last updated
2024-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Disorder

Interventions

Lactobacillus helveticus CCFM1320 group(10^6CFU/Day):Daily oral intake of one packet of probiotics (10^6 CFU)
Lactobacillus helveticus CCFM1320 group(10^9CFU/Day):Daily oral intake of one packet of probiotics (10^9 CFU)

Sponsors

Yixing People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. There are no restrictions on gender and race; 2. Aged 18-65 years; 3. Participants met the International Classification of Sleep Disorders edition 3,(ICSD-3) criteria for the diagnosis of insomnia; 4. Pittsburgh sleep quality index (PSQI) >= 7; 5. Good compliance, able to abide by the requirements of clinical trials; 6. The subject or guardian has signed the informed consent; 7. The subjects fill in the written informed consent form, basic information questionnaire, dietary structure and living condition questionnaire, and promise to cooperate with the research throughout the trial period.

Exclusion criteria

Exclusion criteria: 1. History of ingestion of other probiotics and related products within 4 weeks; 2. History of antibiotic intake within 8 weeks; 3. Allergic to the ingredients of the probiotic product; 4. Those who cannot comply with observation due to working the night shift, irregular lifestyles, or alcoholism; 5. Pregnant or breastfeeding women; 6. People during the preparation for pregnancy.

Design outcomes

Primary

MeasureTime frame
Pittsburgh Sleep Quality Index (PSQI);Athens Insomnia Scale (AIS);

Secondary

MeasureTime frame
Serological indicators; Indicators of saliva;Stool indicators;plasma biochemical index;

Countries

China

Contacts

Public ContactXiaojie Zhang

Yixing People’s Hospital

693258223@qq.com+86 133 5811 9626

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026